These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2050662)

  • 21. Functional importance of the A chain loop in relaxin and insulin.
    Büllesbach EE; Schwabe C
    J Biol Chem; 1994 May; 269(18):13124-8. PubMed ID: 8175738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranes.
    Cara JF; Mirmira RG; Nakagawa SH; Tager HS
    J Biol Chem; 1990 Oct; 265(29):17820-5. PubMed ID: 2170397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of main-chain flexibility and the insulin fold in insulin-receptor interactions.
    Nakagawa SH; Tager HS
    Biochemistry; 1993 Jul; 32(28):7237-43. PubMed ID: 8343513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of the A2 amino acid residue in the biological activity of insulin: [2-glycine-A]- and [2-alanine-A]insulins.
    Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1984 Mar; 23(7):1405-13. PubMed ID: 6372857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steric requirements at position B12 for high biological activity in insulin.
    Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
    Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
    Mirmira RG; Tager HS
    Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A spectroscopic investigation of the conformational dynamics of insulin in solution.
    Pittman I; Tager HS
    Biochemistry; 1995 Aug; 34(33):10578-90. PubMed ID: 7654714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin analogues with permuted A chain N-terminus (author's transl)].
    Krail G; Brandenburg D; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):981-96. PubMed ID: 1181282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A superactive insulin: [B10-aspartic acid]insulin(human).
    Schwartz GP; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6408-11. PubMed ID: 3306677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT; Schwartz G; Katsoyannis PG
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein structure and the spandrels of San Marco: insulin's receptor-binding surface is buttressed by an invariant leucine essential for its stability.
    Weiss MA; Nakagawa SH; Jia W; Xu B; Hua QX; Chu YC; Wang RY; Katsoyannis PG
    Biochemistry; 2002 Jan; 41(3):809-19. PubMed ID: 11790102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
    Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-function relationships of des-(B26-B30)-insulin.
    Spoden M; Gattner HG; Zahn H; Brandenburg D
    Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation, receptor binding affinity, and potency of insulin from the Atlantic hagfish (Myxine glutinosa) determined in isolated rat fat cells.
    Gammeltoft S; Gliemann J
    J Biol Chem; 1977 Jan; 252(2):602-8. PubMed ID: 556725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biophysical optimization of a therapeutic protein by nonstandard mutagenesis: studies of an iodo-insulin derivative.
    Pandyarajan V; Phillips NB; Cox GP; Yang Y; Whittaker J; Ismail-Beigi F; Weiss MA
    J Biol Chem; 2014 Aug; 289(34):23367-81. PubMed ID: 24993826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain.
    Nakagawa SH; Zhao M; Hua QX; Hu SQ; Wan ZL; Jia W; Weiss MA
    Biochemistry; 2005 Apr; 44(13):4984-99. PubMed ID: 15794637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of side-chain characteristics on stability and oligomerization state of a de novo-designed model coiled-coil: 20 amino acid substitutions in position "d".
    Tripet B; Wagschal K; Lavigne P; Mant CT; Hodges RS
    J Mol Biol; 2000 Jul; 300(2):377-402. PubMed ID: 10873472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
    Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA
    Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine.
    Du H; Shi J; Cui D; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):133-9. PubMed ID: 18235975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
    Linde S; Sonne O; Hansen B; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.